Atypical


Journal

JCO precision oncology
ISSN: 2473-4284
Titre abrégé: JCO Precis Oncol
Pays: United States
ID NLM: 101705370

Informations de publication

Date de publication:
Dec 2019
Historique:
entrez: 1 2 2022
pubmed: 1 12 2019
medline: 1 12 2019
Statut: ppublish

Résumé

To describe the clinical and molecular features of metastatic colorectal cancers (mCRCs) bearing uncommon atypical By exploiting five next-generation sequencing sources (Italian collaboration, Memorial Sloan Kettering Cancer Center, Samsung Medical Center, the Biomarker Research for Anti-EGFR Monoclonal Antibodies by Comprehensive Cancer Genomics (BREAC) study, and the Foundation Medicine database), we retrieved 175 At- At- At-

Identifiants

pubmed: 35100719
doi: 10.1200/PO.19.00136
pmc: PMC10445785
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-11

Subventions

Organisme : NCI NIH HHS
ID : P30 CA008748
Pays : United States

Commentaires et corrections

Type : ErratumIn

Références

Nat Rev Cancer. 2011 Oct 13;11(11):761-74
pubmed: 21993244
Ann Oncol. 2015 Oct;26(10):2092-7
pubmed: 26153495
Ann Oncol. 2018 Jan 1;29(1):44-70
pubmed: 29155929
Genome Res. 2018 Nov;28(11):1747-1756
pubmed: 30341162
Nucleic Acids Res. 2012 Nov;40(21):e169
pubmed: 22904074
Lancet Oncol. 2015 Oct;16(13):1306-15
pubmed: 26338525
Target Oncol. 2016 Jun;11(3):363-70
pubmed: 26661077
Front Genet. 2012 Jan 03;2:100
pubmed: 22303394
J Clin Oncol. 2019 Nov 20;37(33):3099-3110
pubmed: 31539295
Ann Oncol. 2017 Dec 01;28(12):3009-3014
pubmed: 29045518
Br J Cancer. 2017 Nov 7;117(10):1450-1458
pubmed: 28972961
Genome Med. 2017 Apr 19;9(1):34
pubmed: 28420421
J Gastrointest Oncol. 2018 Aug;9(4):610-617
pubmed: 30151257
JCO Precis Oncol. 2019 Dec;3:1-5
pubmed: 35100706
Hum Genomics. 2017 Jun 21;11(1):13
pubmed: 28637487
PLoS One. 2012;7(10):e46688
pubmed: 23056405
Lancet Gastroenterol Hepatol. 2016 Nov;1(3):207-216
pubmed: 28404093
Cell. 2010 Jan 22;140(2):209-21
pubmed: 20141835
Cancer Res. 2010 Jul 15;70(14):5901-11
pubmed: 20570890
Nucleic Acids Res. 2011 Sep 1;39(17):e118
pubmed: 21727090
Crit Rev Oncol Hematol. 2015 Oct;96(1):156-66
pubmed: 26088456
Cancer Cell. 2018 Jan 8;33(1):125-136.e3
pubmed: 29316426
Nat Methods. 2015 Nov;12(11):1002-3
pubmed: 26513549
Nature. 2017 Aug 10;548(7666):234-238
pubmed: 28783719
Nat Protoc. 2009;4(7):1073-81
pubmed: 19561590
N Engl J Med. 2013 Sep 12;369(11):1023-34
pubmed: 24024839

Auteurs

Filippo Pietrantonio (F)

Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Università degli Studi di Milano, Milan, Italy.

Rona Yaeger (R)

Memorial Sloan Kettering Cancer Center, New York, NY.

Alexa B Schrock (AB)

Foundation Medicine, Cambridge, MA.

Giovanni Randon (G)

Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

Sandra Romero-Cordoba (S)

Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.

Daniele Rossini (D)

Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy.
University of Pisa, Pisa, Italy.

Giovanni Fucà (G)

Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

Jeffrey S Ross (JS)

Foundation Medicine, Cambridge, MA.
SUNY Upstate Medical University, Syracuse, NY.

Daisuke Kotani (D)

National Cancer Center Hospital East, Kashiwa, Japan.

Russell Madison (R)

Foundation Medicine, Cambridge, MA.

Seung Tae Kim (ST)

Sungkyunkwan University School of Medicine, Seoul, Korea.

Lisa Salvatore (L)

Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.

Alessandra Raimondi (A)

Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

Filippo Pagani (F)

Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

Beatrice Borelli (B)

Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy.
University of Pisa, Pisa, Italy.

Federica Perrone (F)

Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

Maria Di Bartolomeo (M)

Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

Vincent A Miller (VA)

Foundation Medicine, Cambridge, MA.

Siraj M Ali (SM)

Foundation Medicine, Cambridge, MA.

Jeeyun Lee (J)

Sungkyunkwan University School of Medicine, Seoul, Korea.

Takayuki Yoshino (T)

National Cancer Center Hospital East, Kashiwa, Japan.

Filippo de Braud (F)

Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Università degli Studi di Milano, Milan, Italy.

Alfredo Falcone (A)

Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy.
University of Pisa, Pisa, Italy.

Jaclyn F Hechtman (JF)

Memorial Sloan Kettering Cancer Center, New York, NY.

Chiara Cremolini (C)

Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy.
University of Pisa, Pisa, Italy.

Classifications MeSH